Doctors Without Borders/Médecins Sans Frontières (MSF) frequently publishes updates, press releases, and other forms of communication about its work in more than 60 countries around the world. See the list below for the most recent updates or search by location, topic, or year.

Country/Region

Topic

July 05, 2017

Two days ahead of the G20 summit in Germany, the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) and the Stop TB Partnership released a report that shows countries are lagging behind in tackling tuberculosis (TB), introducing the best diagnostic devices, and implementing globally-recommended policies. The third edition of the “Out of Step” report reviews TB policies and practices in 29[1] countries–which account for 82 percent of the global TB burden–and shows that countries can do much more to prevent, diagnose, and treat people affected by TB.

May 25, 2017

Ahead of the G7 summit that’s starting tomorrow in Italy, the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) is urging participating countries to address high medicine prices and drug-resistant infections, which affect people everywhere. Today, across the G7, countries are struggling to pay for new medicines to treat life-threatening illnesses like hepatitis C.

March 24, 2017

Patients with drug-resistant tuberculosis (MDR-TB) have to take a fistful of pills and injections daily for up to two years. Side effects of these toxic drugs can include permanent deafness, nausea and vomiting, blindness, and psychosis. After decades without any new TB drugs, two powerful, less toxic medicines were finally released five years ago. But most patients can't get access to them. This needs to change.

March 24, 2017

NEW YORK, MARCH 24, 2017—Today, World Tuberculosis Day, Doctors Without Borders/Médecins Sans Frontières’ (MSF) is urging pharmaceutical corporations, Sequella and Pfizer, to provide open access to all existing clinical data on a promising drug, sutezolid, to help accelerate the research and development of urgently needed new, lifesaving TB treatment regimes. This data, if not released, will take years and resources to replicate, further delaying new treatment options for people living with TB.

March 23, 2017

Companies and countries must take urgent action to increase access to these lifesaving treatments

March 21, 2017

Winile is a multidrug-resistant tuberculosis (MDR-TB) patient with Doctors Without Borders/Médecins Sans Frontières (MSF) in Swaziland, and one of the many who have lost their hearing due to the toxicity of available MDR-TB drugs. Through an MSF program in Swaziland, she has learned sign language so she can continue to communicate.

February 23, 2017

"You see, I am healed," says Tholakele as she walks around her ward demonstrating her recovery. "Even my legs don't give me problems anymore. Now I can walk perfectly. I walk around the hospital; go out for fresh air and come back when I’m ready."

Tholakele, 39, has drug-resistant tuberculosis (DR-TB) and started treatment in May 2016 at the Moneni National TB Hospital, supported by Doctors Without Borders/Médecins Sans Frontières (MSF) in central Swaziland.

January 24, 2017

While deal marks a critical step in the fight against TB, health groups warn that the deal lacks safeguards that would ensure worldwide affordability

January 19, 2017

NEW YORK, JANUARY 20, 2017—The international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) began a new clinical trial this week in Uzbekistan to develop a radically improved course of treatment for drug-resistant tuberculosis (DR-TB).

The trial aims to find a treatment regimen for DR-TB that is drastically shorter, more effective, and causes fewer side effects than the current treatment options.

Pages